Oncology
1 drug is in development for Glioblastoma Multiforme (GBM).
- Companies
- 1
- Clinical trials
- 5
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Glioblastoma Multiforme (GBM) pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| oncr-719 | Oncorus, Inc. (ONCR) |
About this indication
Glioblastoma Multiforme (GBM) context
Oncology·MeSH: Glioblastoma (D005909)
Narrower concept of MeSH descriptor Glioblastoma
Prevalence
3.2 / 100K
Incidence
3.2 / 100K/yr
Frequently asked questions
How many drugs are in development for Glioblastoma Multiforme (GBM)?
BioSniper tracks 1 drug in development for Glioblastoma Multiforme (GBM) across 1 company.
How many clinical trials target Glioblastoma Multiforme (GBM)?
There are 5 clinical trials targeting Glioblastoma Multiforme (GBM) tracked by BioSniper.
What is the prevalence of Glioblastoma Multiforme (GBM)?
The estimated prevalence of Glioblastoma Multiforme (GBM) is approximately 3.2 per 100,000 population.